»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 1,290¸¸ ´Þ·¯, 2030³â±îÁö 2,357¸¸ ´Þ·¯¿¡ À̸£°í, 2024³â-2030³âÀÇ ¿¹Ãø ±â°£¿¡ CAGR·Î 9.03%ÀÇ ¼ºÀåÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, °¢ Áö¿ª ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, ½ÃÀå ¿ªÇÐ, °æÀï ±¸µµ µîÀ» Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå º¸°í¼ °³¿ä
Á¶»ç ¹üÀ§
½ÃÀå ºÐ¼® : À¯Çüº°
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð ¼ºÀå·ü : À¯Çüº°(2019³â¡¤2023³â¡¤2030³â)
300nm
200nm
100nm
±âŸ
½ÃÀå : ¿ëµµº°
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : ¿ëµµº°(2019³â¡¤2023³â¡¤2030³â)
Á¾¾ç¸¶Ä¿ °Ë»ç
°©»ó¼± ±â´É °Ë»ç
¼ºÈ£¸£¸ó °Ë»ç
°¨¿°Áõ °Ë»ç
½ÉÇ÷°ü ¹× ½ÉÀå ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç
±âŸ
ÀüÁ¦Á¶°Ç°ú Á¦ÇÑ
Á¶»ç ¸ñÀû
Á¶»ç³â
Á¦2Àå ¼¼°èÀÇ ¼ºÀå µ¿Çâ
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Àü¸Á(2019³â-2030³â)
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : Áö¿ªº°(2019³â¡¤2023³â¡¤2030³â)
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ¸ÅÃâ ½ÃÀå Á¡À¯À² : Áö¿ªº°(2019³â-2024³â)
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ¸ÅÃâ ¿¹Ãø : Áö¿ªº°(2025³â-2030³â)
Áö¿ª ½ÃÀå ºÐ¼® : ½ÃÀå ÆÑÆ® ¹× ¼öÄ¡
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ Ãß»ê°ú ¿¹Ãø(2019³â-2030³â)
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ Ãß»ê°ú ¿¹Ãø(2019³â-2030³â)
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ Ãß»ê°ú ¿¹Ãø(2019³â-2030³â)
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ Ãß»ê°ú ¿¹Ãø(2019³â-2030³â)
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ Ãß»ê°ú ¿¹Ãø(2019³â-2030³â)
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ Ãß»ê°ú ¿¹Ãø(2019³â-2030³â)
Á¦3Àå ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ °æÀï ±¸µµ : ±â¾÷º°
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ÁÖ¿ä ±â¾÷ : ¸ÅÃ⺰
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ÁÖ¿ä ±â¾÷ : ¸ÅÃ⺰(2019³â-2024³â)
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ¸ÅÃâ ½ÃÀå Á¡À¯À² : ±â¾÷º°(2019³â-2024³â)
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : ±â¾÷ À¯Çüº°(Tier 1¡¤Tier 2¡¤Tier 3)
´ë»ó ±â¾÷ : ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ¸ÅÃâ ¼øÀ§
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ÁýÁßµµ ºñÀ²
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ÁýÁßµµºñ(CR5¿Í HHI)
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ÆÇ¸Å »óÀ§ 3»ç, ÁÖ¿ä 5°³»ç(2023³â)
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ÁÖ¿ä ±â¾÷ º»»ç, ¼ºñ½º Á¦°ø ¿¡¾î¸®¾î
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ÁÖ¿ä ±â¾÷, Á¦Ç°, ¿ëµµ
Á¦4Àå ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ºÐ¼® µ¥ÀÌÅÍ : À¯Çüº°
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2019³â-2024³â)
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð ¿¹Ãø : À¯Çüº°(2025³â-2030³â)
Á¦5Àå ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ºÐ¼® µ¥ÀÌÅÍ : ¿ëµµº°
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2019³â-2024³â)
¼¼°èÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð ¿¹Ãø : ¿ëµµº°(2025³â-2030³â)
Á¦6Àå ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ÆÑÆ® ¹× ¼öÄ¡
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ¸ÅÃâ : ±â¾÷º°(2019³â-2024³â)
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2019³â-2024³â)
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2025³â-2030³â)
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : À¯Çüº°(2019³â-2030³â)
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2019³â-2024³â)
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2025³â-2030³â)
ºÏ¹ÌÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : ¿ëµµº°(2019³â-2030³â)
Á¦7Àå À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ÆÑÆ® ¹× ¼öÄ¡
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ¸ÅÃâ : ±â¾÷º°(2019³â-2024³â)
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2019³â-2024³â)
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2025³â-2030³â)
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : À¯Çüº°(2019³â-2030³â)
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2019³â-2024³â)
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2025³â-2030³â)
À¯·´ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : ¿ëµµº°(2019³â-2030³â)
Á¦8Àå Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ÆÑÆ® ¹× ¼öÄ¡
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ÆÇ¸Å : ±â¾÷º°(2019³â-2024³â)
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2019³â-2024³â)
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2025³â-2030³â)
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : À¯Çüº°(2019³â-2030³â)
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2019³â-2024³â)
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2025³â-2030³â)
Áß±¹ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : ¿ëµµº°(2019³â-2030³â)
Á¦9Àå ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ÆÑÆ® ¹× ¼öÄ¡
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ¸ÅÃâ : ±â¾÷º°(2019³â-2024³â)
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2019³â-2024³â)
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2025³â-2030³â)
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : À¯Çüº°(2019³â-2030³â)
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2019³â-2024³â)
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2025³â-2030³â)
ÀϺ»ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : ¿ëµµº°(2019³â-2030³â)
Á¦10Àå ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ÆÑÆ® ¹× ¼öÄ¡
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ¸ÅÃâ : ±â¾÷º°(2019³â-2024³â)
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2019³â-2024³â)
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2025³â-2030³â)
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : À¯Çüº°(2019³â-2030³â)
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2019³â-2024³â)
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2025³â-2030³â)
ÀεµÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : ¿ëµµº°(2019³â-2030³â)
Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ÆÑÆ® ¹× ¼öÄ¡
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ¸ÅÃâ : ±â¾÷º°(2019³â-2024³â)
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2019³â-2024³â)
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : À¯Çüº°(2025³â-2030³â)
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : À¯Çüº°(2019³â-2030³â)
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2019³â-2024³â)
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ±Ô¸ð : ¿ëµµº°(2025³â-2030³â)
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå Á¡À¯À² : ¿ëµµº°(2019³â-2030³â)
Á¦12Àå ÁÖ¿ä ±â¾÷ °³¿ä
Thermo Fisher Scientific
Merck
Bangs Laboratories, Inc.
Suzhou NanoMicro Technology Co
Polysciences Inc.
CD Bioparticles
Hangzhou Bioeast Biotech Co
Nanjing Microdetection
Á¦13Àå ¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ¿ªÇÐ
¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ »ê¾÷ µ¿Çâ
¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
¹ÙÀÌ¿À ºÎ¹®¿ë À¯·ÎÇÇ¿ò ³ª³ëÀÔÀÚ ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
Á¦14Àå Á¶»ç °á°ú¿Í °á·Ð
Á¦15Àå ºÎ·Ï
LSH
The global Europium Nanoparticle in Biological Sector market size was US$ 12.90 million in 2023 and is forecast to a readjusted size of US$ 23.57 million by 2030 with a CAGR of 9.03% during the forecast period 2024-2030.
The global key players of Europium Nanoparticle in Biological Sector include Thermo Fisher Scientific, Merck, Suzhou NanoMicro Technology Co, Bangs Laboratories, Inc. and Polysciences Inc., accounting for 86.93% market share in terms of revenues in 2023. The market concentration rate is relatively high.
The global Europium Nanoparticle in Biological Sector market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Europium Nanoparticle in Biological Sector market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2019-2030.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Bangs Laboratories, Inc.
Suzhou NanoMicro Technology Co
Polysciences Inc.
CD Bioparticles
Hangzhou Bioeast Biotech Co
Nanjing Microoetection
Segment by Type
300 nm
200 nm
100 nm
Other
Segment by Application
Tumor Marker Testing
Thyroid Function Testing
Sex Hormone Testing
Infectious Disease Testing
Cardiovascular and Cardiac Biomarkers Testing
Other
By Region
North America
Europe
China
Japan
India
Latin America
Other Regions
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Europium Nanoparticle in Biological Sector in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Europium Nanoparticle in Biological Sector manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by Type, and by Application, revenue for each segment.
Chapter 7: Europe by company, by Type, and by Application, revenue for each segment.
Chapter 8: China by company, by Type, and by Application, revenue for each segment.
Chapter 9: Japan by company, by Type, and by Application, revenue for each segment.
Chapter 10: India by company, by Type, and by Application, revenue for each segment.
Chapter 11: Latin America by company, by Type, and by Application, revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Europium Nanoparticle in Biological Sector revenue, gross margin, and recent development, etc.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Europium Nanoparticle in Biological Sector Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 300 nm
1.2.3 200 nm
1.2.4 100 nm
1.2.5 Other
1.3 Market by Application
1.3.1 Global Europium Nanoparticle in Biological Sector Market Share by Application: 2019 VS 2023 VS 2030
1.3.2 Tumor Marker Testing
1.3.3 Thyroid Function Testing
1.3.4 Sex Hormone Testing
1.3.5 Infectious Disease Testing
1.3.6 Cardiovascular and Cardiac Biomarkers Testing
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Europium Nanoparticle in Biological Sector Market Perspective (2019-2030)
2.2 Global Europium Nanoparticle in Biological Sector Market Size by Region: 2019 VS 2023 VS 2030
2.3 Global Europium Nanoparticle in Biological Sector Revenue Market Share by Region (2019-2024)
2.4 Global Europium Nanoparticle in Biological Sector Revenue Forecast by Region (2025-2030)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 North America Europium Nanoparticle in Biological Sector Estimates and Projections (2019-2030)
2.5.2 Europe Europium Nanoparticle in Biological Sector Estimates and Projections (2019-2030)
2.5.3 China Europium Nanoparticle in Biological Sector Estimates and Projections (2019-2030)
2.5.4 Japan Europium Nanoparticle in Biological Sector Estimates and Projections (2019-2030)
2.5.5 India Europium Nanoparticle in Biological Sector Estimates and Projections (2019-2030)
2.5.6 Latin America Europium Nanoparticle in Biological Sector Estimates and Projections (2019-2030)
3 Europium Nanoparticle in Biological Sector Competition Landscape by Players
3.1 Global Top Europium Nanoparticle in Biological Sector Players by Revenue
3.1.1 Global Top Europium Nanoparticle in Biological Sector Players by Revenue (2019-2024)
3.1.2 Global Europium Nanoparticle in Biological Sector Revenue Market Share by Players (2019-2024)
3.2 Global Europium Nanoparticle in Biological Sector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Europium Nanoparticle in Biological Sector Revenue
3.4 Global Europium Nanoparticle in Biological Sector Market Concentration Ratio
3.4.1 Global Europium Nanoparticle in Biological Sector Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 3 and Top 5 Companies by Europium Nanoparticle in Biological Sector Revenue in 2023
3.5 Global Key Players of Europium Nanoparticle in Biological Sector Head office and Area Served
3.6 Global Key Players of Europium Nanoparticle in Biological Sector, Product and Application
4 Europium Nanoparticle in Biological Sector Breakdown Data by Type
4.1 Global Europium Nanoparticle in Biological Sector Historic Market Size by Type (2019-2024)
4.2 Global Europium Nanoparticle in Biological Sector Forecasted Market Size by Type (2025-2030)
5 Europium Nanoparticle in Biological Sector Breakdown Data by Application
5.1 Global Europium Nanoparticle in Biological Sector Historic Market Size by Application (2019-2024)
5.2 Global Europium Nanoparticle in Biological Sector Forecasted Market Size by Application (2025-2030)
6 North America Europium Nanoparticle in Biological Sector Market Facts & Figures
6.1 North America Europium Nanoparticle in Biological Sector Revenue by Company (2019-2024)
6.2 North America Europium Nanoparticle in Biological Sector Market Size by Type
6.2.1 North America Europium Nanoparticle in Biological Sector Market Size by Type (2019-2024)
6.2.2 North America Europium Nanoparticle in Biological Sector Market Size by Type (2025-2030)
6.2.3 North America Europium Nanoparticle in Biological Sector Market Share by Type (2019-2030)
6.3 North America Europium Nanoparticle in Biological Sector Market Size by Application
6.3.1 North America Europium Nanoparticle in Biological Sector Market Size by Application (2019-2024)
6.3.2 North America Europium Nanoparticle in Biological Sector Market Size by Application (2025-2030)
6.3.3 North America Europium Nanoparticle in Biological Sector Market Share by Application (2019-2030)
7 Europe Europium Nanoparticle in Biological Sector Market Facts & Figures
7.1 Europe Europium Nanoparticle in Biological Sector Revenue by Company (2019-2024)
7.2 Europe Europium Nanoparticle in Biological Sector Market Size by Type
7.2.1 Europe Europium Nanoparticle in Biological Sector Market Size by Type (2019-2024)
7.2.2 Europe Europium Nanoparticle in Biological Sector Market Size by Type (2025-2030)
7.2.3 Europe Europium Nanoparticle in Biological Sector Market Share by Type (2019-2030)
7.3 Europe Europium Nanoparticle in Biological Sector Market Size by Application
7.3.1 Europe Europium Nanoparticle in Biological Sector Market Size by Application (2019-2024)
7.3.2 Europe Europium Nanoparticle in Biological Sector Market Size by Application (2025-2030)
7.3.3 Europe Europium Nanoparticle in Biological Sector Market Share by Application (2019-2030)
8 China Europium Nanoparticle in Biological Sector Market Facts & Figures
8.1 China Europium Nanoparticle in Biological Sector Revenue by Company (2019-2024)
8.2 China Europium Nanoparticle in Biological Sector Market Size by Type
8.2.1 China Europium Nanoparticle in Biological Sector Market Size by Type (2019-2024)
8.2.2 China Europium Nanoparticle in Biological Sector Market Size by Type (2025-2030)
8.2.3 China Europium Nanoparticle in Biological Sector Market Share by Type (2019-2030)
8.3 China Europium Nanoparticle in Biological Sector Market Size by Application
8.3.1 China Europium Nanoparticle in Biological Sector Market Size by Application (2019-2024)
8.3.2 China Europium Nanoparticle in Biological Sector Market Size by Application (2025-2030)
8.3.3 China Europium Nanoparticle in Biological Sector Market Share by Application (2019-2030)
9 Japan Europium Nanoparticle in Biological Sector Market Facts & Figures
9.1 Japan Europium Nanoparticle in Biological Sector Revenue by Company (2019-2024)
9.2 Japan Europium Nanoparticle in Biological Sector Market Size by Type
9.2.1 Japan Europium Nanoparticle in Biological Sector Market Size by Type (2019-2024)
9.2.2 Japan Europium Nanoparticle in Biological Sector Market Size by Type (2025-2030)
9.2.3 Japan Europium Nanoparticle in Biological Sector Market Share by Type (2019-2030)
9.3 Japan Europium Nanoparticle in Biological Sector Market Size by Application
9.3.1 Japan Europium Nanoparticle in Biological Sector Market Size by Application (2019-2024)
9.3.2 Japan Europium Nanoparticle in Biological Sector Market Size by Application (2025-2030)
9.3.3 Japan Europium Nanoparticle in Biological Sector Market Share by Application (2019-2030)
10 India Europium Nanoparticle in Biological Sector Market Facts & Figures
10.1 India Europium Nanoparticle in Biological Sector Revenue by Company (2019-2024)
10.2 India Europium Nanoparticle in Biological Sector Market Size by Type
10.2.1 India Europium Nanoparticle in Biological Sector Market Size by Type (2019-2024)
10.2.2 India Europium Nanoparticle in Biological Sector Market Size by Type (2025-2030)
10.2.3 India Europium Nanoparticle in Biological Sector Market Share by Type (2019-2030)
10.3 India Europium Nanoparticle in Biological Sector Market Size by Application
10.3.1 India Europium Nanoparticle in Biological Sector Market Size by Application (2019-2024)
10.3.2 India Europium Nanoparticle in Biological Sector Market Size by Application (2025-2030)
10.3.3 India Europium Nanoparticle in Biological Sector Market Share by Application (2019-2030)
11 Latin America Europium Nanoparticle in Biological Sector Market Facts & Figures
11.1 Latin America Europium Nanoparticle in Biological Sector Revenue by Company (2019-2024)
11.2 Latin America Europium Nanoparticle in Biological Sector Market Size by Type
11.2.1 Latin America Europium Nanoparticle in Biological Sector Market Size by Type (2019-2024)
11.2.2 Latin America Europium Nanoparticle in Biological Sector Market Size by Type (2025-2030)
11.2.3 Latin America Europium Nanoparticle in Biological Sector Market Share by Type (2019-2030)
11.3 Latin America Europium Nanoparticle in Biological Sector Market Size by Application
11.3.1 Latin America Europium Nanoparticle in Biological Sector Market Size by Application (2019-2024)
11.3.2 Latin America Europium Nanoparticle in Biological Sector Market Size by Application (2025-2030)
11.3.3 Latin America Europium Nanoparticle in Biological Sector Market Share by Application (2019-2030)
12 Key Players Profiles
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Details
12.1.2 Thermo Fisher Scientific Business Overview
12.1.3 Thermo Fisher Scientific Europium Nanoparticle in Biological Sector Introduction
12.1.4 Thermo Fisher Scientific Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Merck Business Overview
12.2.3 Merck Europium Nanoparticle in Biological Sector Introduction
12.2.4 Merck Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
12.3 Bangs Laboratories, Inc.
12.3.1 Bangs Laboratories, Inc. Company Details
12.3.2 Bangs Laboratories, Inc. Business Overview
12.3.3 Bangs Laboratories, Inc. Europium Nanoparticle in Biological Sector Introduction
12.3.4 Bangs Laboratories, Inc. Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
12.4 Suzhou NanoMicro Technology Co
12.4.1 Suzhou NanoMicro Technology Co Company Details
12.4.2 Suzhou NanoMicro Technology Co Business Overview
12.4.3 Suzhou NanoMicro Technology Co Europium Nanoparticle in Biological Sector Introduction
12.4.4 Suzhou NanoMicro Technology Co Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
12.5 Polysciences Inc.
12.5.1 Polysciences Inc. Company Details
12.5.2 Polysciences Inc. Business Overview
12.5.3 Polysciences Inc. Europium Nanoparticle in Biological Sector Introduction
12.5.4 Polysciences Inc. Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
12.6 CD Bioparticles
12.6.1 CD Bioparticles Company Details
12.6.2 CD Bioparticles Business Overview
12.6.3 CD Bioparticles Europium Nanoparticle in Biological Sector Introduction
12.6.4 CD Bioparticles Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
12.7 Hangzhou Bioeast Biotech Co
12.7.1 Hangzhou Bioeast Biotech Co Company Details
12.7.2 Hangzhou Bioeast Biotech Co Business Overview
12.7.3 Hangzhou Bioeast Biotech Co Europium Nanoparticle in Biological Sector Introduction
12.7.4 Hangzhou Bioeast Biotech Co Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
12.8 Nanjing Microdetection
12.8.1 Nanjing Microdetection Company Details
12.8.2 Nanjing Microdetection Business Overview
12.8.3 Nanjing Microdetection Europium Nanoparticle in Biological Sector Introduction
12.8.4 Nanjing Microdetection Revenue in Europium Nanoparticle in Biological Sector Business (2019-2024)
13 Europium Nanoparticle in Biological Sector Market Dynamics
13.1 Europium Nanoparticle in Biological Sector Industry Trends
13.2 Europium Nanoparticle in Biological Sector Market Drivers
13.3 Europium Nanoparticle in Biological Sector Market Challenges
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer